ProMIS Neurosciences PMN
NASDAQ PMN
$10.02 +0.74 (+8.04%)
As of: Oct 2, 2026 · 10:18 AM EDT

ProMIS Neurosciences (PMN) Net Equity Issued and Repurchased (2021 - 2024)

Updated

ProMIS Neurosciences (PMN) recorded Net Equity Issued and Repurchased of $708,468 in FY2025, up 272.3% from $190,274 in FY2024.

Analysis

ProMIS Neurosciences (PMN) Net Equity Issued and Repurchased (2021 - 2024) Analysis & Trends

Starting with FY2021, ProMIS Neurosciences' Net Equity Issued and Repurchased history includes 5 years.

  • Annual Net Equity Issued and Repurchased has a four-year compound annual growth rate of -54.0% (FY2021 to FY2025).
  • The FY2025 figure is the highest annual Net Equity Issued and Repurchased since FY2022.
  • Per Business Quant data, PMN's Net Equity Issued and Repurchased was $190,274 in FY2024, $3,600 in FY2023 (-99.9%), $4.97 million in FY2022 (-68.7%) and $15.87 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 ProMIS Neurosciences 97.30 Mn -41.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 190,274.00
Dec 31, 2021 445.00
API Access

ProMIS Neurosciences Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PMN&period=max&api_key=YOUR_API_KEY